Ocular Therapeutics/ (Record no. 6327)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 04218nam a22002417a 4500 |
003 - CONTROL NUMBER IDENTIFIER | |
control field | KENaKMTC |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20210120055949.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 210120b ||||| |||| 00| 0 eng d |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
International Standard Book Number | 9789350903209 |
040 ## - CATALOGING SOURCE | |
Transcribing agency | dlc |
050 ## - LIBRARY OF CONGRESS CALL NUMBER | |
Classification number | RE991.G37 2013 |
100 ## - MAIN ENTRY--PERSONAL NAME | |
Personal name | |
245 ## - TITLE STATEMENT | |
Title | Ocular Therapeutics/ |
Statement of responsibility, etc | Editor: Ashock Garg |
250 ## - EDITION STATEMENT | |
Edition statement | 3rd ed.: |
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) | |
Place of publication, distribution, etc | New Delhi: |
Name of publisher, distributor, etc | Jaypee-Highlights Medical Publishers, |
Date of publication, distribution, etc | c2013 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | xxxvi, 1059P.: |
Other physical details | col. ill.; |
Dimensions | 24 cm. |
504 ## - BIBLIOGRAPHY, ETC. NOTE | |
Bibliography, etc | Includes Bibliographical references and Index |
505 ## - FORMATTED CONTENTS NOTE | |
Formatted contents note | CONTENTS<br/>Section 1: Fundamentals and Preliminary Considerations in Ocular Therapeutics Ocular Defense SystemTear Film PhysiologyAqueous Humor DynamicsRoutes of Administration and Drug DeliverySystems in OphthalmologyMicroorganisms and Ocular DiseasesUnique Ocular Drug Delivery SystemsAntibacterial TherapyAnti-inflammatory TherapyAntiviral TherapyAntifungal TherapyAntiglaucoma TherapyAntiallergy TherapyLocal Anesthetic AgentsOphthalmic Viscosurgical Devices and Other Ocular Surgical AdjunctsMydriatics and CycloplegicsOphthalmic DyesOcular Lubricants and Artificial Tear SolutionsTopical Immune TherapyTopical Hyperosmotic AgentsAntiretroviral Drug Therapy of Ocular Infections in AIDSSterilization, Disinfection and Antiseptics in OphthalmologyMiscellaneous Drugs in OphthalmologyOcular Drug Toxicity: ComplicationsTopical and Systemic Ophthalmic Drugs with Common DosagesOcular Manifestations of Systemic DiseasesQuick Look Tabulated Ocular Therapeutics Information Section 2: Applied Ocular Therapeutics in Ophthalmic Surgery Comprehensive Review of Topical Ophthalmic Antibacterial Agents: Their Mechanisms of Action and Adverse Effects Including Long-Standing Drugs and the Most Recent PreparationsPreoperative and Postoperative Antibiotic Prophylaxis in Cataract SurgeryManagement of Iatrogenic Inflammation of the EyeManagement of Postrefractive KeratitisOcular Pharmacotherapeutics in Corneal Refractive SurgeryAntioxidants and Their Role in OphthalmologyTetracyclins for Ocular Surface DiseasesClinical Applications of Antimycotic Agents in the EyeRecommended Antibiotic Dosages for Various Clinical Conditions of the EyeEndophthalmitis Prevention StrategiesManagement of Myopic Choroidal NeovascularizationTreatment of Central Serous ChoroidopathyTreatment of Retinal Angiomatous ProliferationConjunctival Allergen Challenge for Evaluating Anti-inflammatory TherapySteroid Therapy for Allergic Ocular DiseaseOptimizing Visual Outcomes with NSAIDs Therapy in Cataract and Refractive SurgeriesImmunosuppressive Drugs in OphthalmologyManagement of Cystoid Macular Edema BlepharitisTrypan Blue in the Management of Mature CataractTrypan Blue Assisted Epiretinal Membrane RemovalPerfluorocarbon Liquids in Vitreoretinal SurgeryUse of Tissue Adhesives in OphthalmologyPhotodynamic Therapy (Verteporfin) in Age-related Macular DegenerationIndocyanine Green AngiographyManagement of Dry Eye-Current Trends and Recent AdvancesManagement of Endophthalmitis: Antibiotic Schedule and DosagesSurgical Techniques of Glued IOLIntraocular GasesPharmacology of Anti-VEGF Therapy Section 3: Recent Advances in Ocular Therapeutics Toxic Anterior Segment SyndromeAnesthesia Trends in OphthalmologyAzithromycin in Ophthalmology: A New TherapyUse of Beta-adrenergic Blockers in Ocular Vascular DiseasesClinical Applications of Anti-inflammatory and Anti-protease Effects of Tetracyclines in Ocular Surface DiseaseOptimized NSAIDs and Antibacterial Regimen is Key to Ocular Surgical Prophylaxis Ophthalmic Medications in Pediatric Age GroupManagement of Uveitis in ChildrenManagement of Anticoagulation Therapy in Elective Ophthalmic ProceduresOcular Pharmacology of Intravitreal Dexamethasone Sustained Release ImplantNanotechnology in OphthalmologyPhotochemical Therapy for Corneal InfectionsRecent and Future Drugs in Ophthalmology |
520 ## - SUMMARY, ETC. | |
Summary, etc | Brings practitioners up to date with the latest advances in ophthalmic drugs, discussing physiology of the eye, drug administration, the fundamental role of ocular therapeutics, the application of ophthalmic drugs and future developments. |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Ophthalmology |
700 ## - ADDED ENTRY--PERSONAL NAME | |
Personal name | Garg, Ashok |
Relator term | Editor |
942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
Source of classification or shelving scheme | Library of Congress Classification |
Koha item type | Books |
Intials | gnw |
Withdrawn status | Lost status | Source of classification or shelving scheme | Damaged status | Not for loan | Home library | Current library | Shelving location | Date acquired | Total Checkouts | Full call number | Barcode | Date last seen | Date checked out | Price effective from | Koha item type |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Library of Congress Classification | KMTC:NAIROBI CAMPUS | KMTC:NAIROBI CAMPUS | General Stacks | 03/06/2019 | 2 | RE991.G37 2013 | 30150 | 15/12/2021 | 03/12/2021 | 03/06/2019 | Books |